6-87477478-A-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_006416.5(SLC35A1):​c.133A>G​(p.Thr45Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00347 in 1,614,086 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 9 hom. )

Consequence

SLC35A1
NM_006416.5 missense

Scores

3
9
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:7

Conservation

PhyloP100: 7.49

Publications

9 publications found
Variant links:
Genes affected
SLC35A1 (HGNC:11021): (solute carrier family 35 member A1) The protein encoded by this gene is found in the membrane of the Golgi apparatus, where it transports nucleotide sugars into the Golgi. One such nucleotide sugar is CMP-sialic acid, which is imported into the Golgi by the encoded protein and subsequently glycosylated. Defects in this gene are a cause of congenital disorder of glycosylation type 2F (CDG2F). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Dec 2009]
SLC35A1 Gene-Disease associations (from GenCC):
  • SLC35A1-congenital disorder of glycosylation
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014591694).
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC35A1NM_006416.5 linkc.133A>G p.Thr45Ala missense_variant Exon 2 of 8 ENST00000369552.9 NP_006407.1
SLC35A1NM_001168398.2 linkc.133A>G p.Thr45Ala missense_variant Exon 2 of 7 NP_001161870.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC35A1ENST00000369552.9 linkc.133A>G p.Thr45Ala missense_variant Exon 2 of 8 1 NM_006416.5 ENSP00000358565.4
ENSG00000213204ENST00000507897.5 linkn.*177A>G non_coding_transcript_exon_variant Exon 14 of 16 2 ENSP00000426769.1
ENSG00000213204ENST00000507897.5 linkn.*177A>G 3_prime_UTR_variant Exon 14 of 16 2 ENSP00000426769.1

Frequencies

GnomAD3 genomes
AF:
0.00251
AC:
382
AN:
152176
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00406
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00274
AC:
689
AN:
251454
AF XY:
0.00266
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.000694
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00416
Gnomad NFE exome
AF:
0.00418
Gnomad OTH exome
AF:
0.00391
GnomAD4 exome
AF:
0.00357
AC:
5213
AN:
1461792
Hom.:
9
Cov.:
31
AF XY:
0.00353
AC XY:
2567
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.000597
AC:
20
AN:
33480
American (AMR)
AF:
0.000984
AC:
44
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00103
AC:
27
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.00184
AC:
159
AN:
86256
European-Finnish (FIN)
AF:
0.00485
AC:
259
AN:
53414
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.00405
AC:
4499
AN:
1111944
Other (OTH)
AF:
0.00325
AC:
196
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
257
514
772
1029
1286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00251
AC:
382
AN:
152294
Hom.:
0
Cov.:
32
AF XY:
0.00263
AC XY:
196
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000602
AC:
25
AN:
41556
American (AMR)
AF:
0.00131
AC:
20
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4824
European-Finnish (FIN)
AF:
0.00282
AC:
30
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00406
AC:
276
AN:
68016
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00330
Hom.:
5
Bravo
AF:
0.00215
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00512
AC:
44
ExAC
AF:
0.00277
AC:
336
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00431
EpiControl
AF:
0.00373

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:4
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jun 22, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 15, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC35A1: BS2

SLC35A1-congenital disorder of glycosylation Pathogenic:1Benign:1
Sep 24, 2024
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 17, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The SLC35A1 p.Thr45Ala variant was not identified in the literature but was identified in dbSNP (ID: rs145006535), LOVD 3.0 and ClinVar (classified as uncertain significance by Illumina and Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics, and as likely benign by Invitae). The variant was identified in control databases in 785 of 282850 chromosomes (3 homozygous) at a frequency of 0.002775 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 542 of 129166 chromosomes (freq: 0.004196), Other in 30 of 7228 chromosomes (freq: 0.004151), European (Finnish) in 104 of 25124 chromosomes (freq: 0.004139), South Asian in 52 of 30612 chromosomes (freq: 0.001699), Latino in 37 of 35440 chromosomes (freq: 0.001044), Ashkenazi Jewish in 9 of 10370 chromosomes (freq: 0.000868) and African in 11 of 24960 chromosomes (freq: 0.000441), but was not observed in the East Asian population. The p.Thr45 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign.

SLC35A1-related disorder Benign:1
Jul 22, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.069
T
BayesDel_noAF
Uncertain
0.13
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0
.;T;D;.
Eigen
Pathogenic
0.85
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D;D;D;D
M_CAP
Benign
0.033
D
MetaRNN
Benign
0.015
T;T;T;T
MetaSVM
Benign
-0.43
T
MutationAssessor
Uncertain
2.8
M;.;M;.
PhyloP100
7.5
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-2.8
D;D;D;.
REVEL
Uncertain
0.54
Sift
Uncertain
0.0050
D;D;D;.
Sift4G
Uncertain
0.014
D;D;D;D
Vest4
0.74
ClinPred
0.038
T
GERP RS
5.6
Varity_R
0.49
gMVP
0.41
Mutation Taster
=189/111
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145006535; hg19: chr6-88187196; API